Anschutz Cancer Pavilion
1665 North Aurora Court
Aurora, CO 80045
A promising new study released by the University of Colorado Cancer Center suggests that recurrence of certain cancers can be significantly decreased by irradiating only a select set of lymph nodes near a tumor rather than all of them.
In the course of her research studying employment and cancer, Cathy J. Bradley, PhD, MPA, deputy director of the University of Colorado Cancer Center, has heard from people diagnosed with cancer who would skip a chemotherapy treatment rather than skip work and risk losing their job.
Xander Bradeen began his undergraduate studies at the University of Colorado Boulder planning to major in neuroscience as a pre-med student, the first in his family to pursue a college education. Then he learned about prairie voles.
New research conducted in the lab of University of Colorado Cancer Center co-deputy director James DeGregori, PhD, may explain why acute myeloid leukemia (AML) cells that reside in the bone marrow are more resistant to medication than AML cells found in the blood and elsewhere in the body.
Laura Foote is now three years out from her pancreatic cancer diagnosis, thanks to a surgery performed by Richard Schulick, MD, MBA, director of the University of Colorado Cancer Center and chair of the Department of Surgery.
University of Colorado Cancer Center member Erin Schenk, MD, PhD, has been named one of the CU School of Medicine 2022 Translational Research Scholars and received four-year grant support to facilitate exploration and new lines of research.
Corralling four research programs, 12 shared resources, a 28-member leadership team, and a $23 million grant is a huge job — but it’s one that Michaela Montour has performed at the University of Colorado Center with ease for more than 20 years.
Mammograms are a vital tool for breast cancer screening. They can detect tumors even before a woman experiences signs or symptoms of cancer, and are sensitive enough to register changes to breast tissue as small as a grain of sand.
A significant body of research has shown that having regular mammograms can lower a woman’s risk of dying from breast cancer.
University of Colorado Cancer Center member Bryan Haugen, MD, always knew he was a science person. His question was if he wanted to be a MD or a PhD. After completing his bachelor’s degree at Saint Olaf College in Minnesota, he did a few years of research at the Mayo Clinic before starting medical school there.
Cancer becomes especially dangerous when it metastasizes — or spreads — to other parts of the body, including the brain. Breast cancer is more likely than many other cancers to spread to the brain, due in part to the large amounts of estrogen present in areas including the hippocampus, hypothalamus, and amygdala.
Amanda Vegter did not have time for whatever it was that she felt on the side of her left breast.
She was six weeks into her fourth year of veterinary school, she had backpacking trips to go on with her boyfriend, walks to go on with her two dogs, plus plans for a summer externship in South Africa. She was busy and happy and it was probably nothing.
But that firm spot she first felt on her breast in January 2021 while working out at her boyfriend’s house didn’t just go away. Now she can look back and shake her head – of course it was breast cancer.
Scarlet Doyle was 29 when she was diagnosed with angiosarcoma, a rare type of breast cancer. She had found a lump and had to advocate for herself to get her breast cancer diagnosis. After having her care transferred to the University of Colorado Cancer Center, she was seen by Breelyn Wilky, MD, associate professor of medical oncology and deputy associate director of clinical research at the CU Cancer Center, and Gretchen Ahrendt, MD, professor of surgical oncology.
Jan Lowery, PhD, MPH, who started her career as a researcher at the University of Colorado Cancer Center, returned September 1 as assistant director for dissemination and implementation for the Office of Community Outreach and Engagement at the CU Cancer Center. In her new role, Lowery will lead efforts to develop, conduct, and disseminate implementation-focused projects in cancer prevention, early detection, and survivorship.
A team of scientists and University of Colorado Cancer Center members are collaborating to understand pre-malignancy in lung cancer and decrease the risk of developing the disease, supported by a grant to promote such multi-investigator research.
The best screening test for colorectal cancer is the screening that gets done, because it decreases a person’s chances of getting colorectal cancer and significantly reduces their risk of dying from colorectal cancer.
As lead investigator or sub-investigator on numerous clinical trials at the University of Colorado Cancer Center — many of them investigating new treatments for head and neck cancer — Jessica McDermott, MD, has been instrumental in improving access to cancer clinical trials for patients from medically underserved communities.
More than 85 researchers from five different institutions around Colorado, including the University of Colorado School of Medicine, Colorado State University, and CU Boulder, gathered in the newly opened Anschutz Health Sciences Building on the CU Anschutz Medical Campus on August 19 for the 2022 Genome Regulation Summer Symposium.
Former “TODAY” show anchor Katie Couric revealed last week that she was diagnosed with breast cancer in summer 2022. Couric appeared on “TODAY” on October 3 to talk about her diagnosis, saying she was lucky her cancer was detected during a routine mammogram and urging other women to keep up with their mammograms.
University of Colorado Cancer Center members Moumita Ghosh, PhD, and Eric Clambey, PhD, have received a grant from the American Lung Association (ALA) to study how epithelial progenitor cells and immune cells may impact each other to shape the outcome of lung cancer.
When a person has lived with colorectal cancer for a long time, and gotten to the point of not responding to therapies as much or at all, it’s common to develop cachexia. This debilitating condition is a multi-systemic wasting syndrome that can cause weight loss, a loss of muscle and bone mass, fatigue, and frailty.
Researchers from the University of Colorado Cancer Center on the University of Colorado Anschutz Medical Campus have created a new way of measuring cancer lesions’ response to treatment that could better inform the development of new cancer drugs.
Prostate cancer is the most common cancer in men and, when caught and treated early, is considered curable. But when prostate cancer becomes metastatic, meaning it spreads to distant organs, it is no longer considered curable and novel treatment strategies are needed.
Prostate cancer is the second most common and deadly cancer in the United States. The American Cancer Society estimates that 1 in 8 men will receive a prostate cancer diagnosis in their lifetime. Treatment techniques range from aggressive therapies such as radical prostatectomy or radiation therapy to targeted therapies that treat only the affected cancer cells.
Every person who receives a cancer diagnosis experiences the symptoms of the disease and treatments differently. However, a common thread is that the disease can influence every aspect of life, even after a person reaches no evidence of disease (NED) status.
Thanks in part to clinical trials overseen by researchers at the University of Colorado Cancer Center, a wearable, portable electrical device called Optune is proving successful at treating a type of brain tumor called a glioblastoma.
As part of its ongoing efforts to eradicate childhood cancers, the St. Baldrick’s Foundation has awarded University of Colorado Cancer Center member Kelly Faulk, MD, a St. Baldrick’s Scholar grant to investigate a new method for treating infant leukemia.
A new phase 2 clinical trial led by University of Colorado Cancer Center member Robert Lentz, MD, may offer hope for patients with metastatic colon cancer for whom standard therapy is no longer effective. Lentz is mentored by Wells Messersmith, MD, associate director of clinical services at the CU Cancer Center.
As genetic counseling and genetic testing continue gaining importance in the world of cancer, the new co-director of hereditary cancers in the University of Colorado Cancer Center is aiming to increase awareness of these important resources for patients.
The prostate-specific antigen (PSA) is a protein produced by the prostate gland. The PSA test is a blood test used to measure the amount of this protein found in the blood. Results are reported (ng/mL), which means nanograms of PSA per milliliter of blood. High levels of PSA have been found in men with advanced prostate cancer.
Initially, the big picture looks severe: Pediatric brain tumors are now the number one cause of death for children diagnosed with cancer.
Though leukemia is four times more common in pediatric patients than brain tumors, about 90% of children diagnosed with leukemia will experience a cure “because we’ve done such a good job of researching leukemia, and treatments have come so far that cure rates have improved significantly,” says Rajeev Vibhakar, MD, PhD, MPH, a professor of pediatric hematology and oncology in the University of Colorado School of Medicine. “We need to see that same level of support and advancement in finding cures for pediatric brain tumors.”
In research that reinforces the University of Colorado Cancer Center’s longstanding relationship with the Leukemia & Lymphoma Society (LLS), CU Cancer Center member Lauren Nicholas, PhD, MPP, is co-principal investigator on a new LLS-funded study to examine the role of Medicare plan selection in dealing with a blood cancer diagnosis.
Each year, about 27,000 women age 45 or younger are diagnosed with breast cancer in the United States. Of those, about 4% are pregnant at the time of their diagnosis.
Researchers at the University of Colorado Anschutz Medical Campus have discovered how to extract critical information about breast cancer tumors and disease progression by analyzing blood plasma rather than using more invasive tissue biopsies.
“This is simply a blood draw,” said the study’s senior co-author Peter Kabos, MD, associate professor of medicine in the medical oncology division at the University of Colorado School of Medicine and CU Cancer Center member. “This allows us to look under the surface to see the defining characteristics of the disease. The advantage is that we don’t need to do repeated tissue biopsies.”
Deaths from COVID-19 and drug overdoses grabbed a lot of the headlines in 2021, but recently released numbers from the Colorado Department of Public Health and Environment show that cancer was still a leading cause of death in the state, and the number-one cause of death for the 45–84 age range.
For Isaiah Richardson, conducting research as an American Cancer Society Diversity in Cancer Research Intern this summer was an important academic and professional experience, but it was also personal.
Less than a year ago, Ken Herfert got a puppy and named her Bailey after the Colorado town where she was born.
This was a big deal for several reasons, including the responsibility of adopting a new family member, but perhaps the biggest was this: About six months after receiving a diagnosis of esophageal cancer in early 2018, Herfert’s oncologist in California told him he had maybe a year to live, maybe less.
The effects of cancer are not just physical, especially in advanced stages of the disease. People living with a cancer diagnosis may experience depression, anxiety, and fear, or feel demoralized by the weight of new and unanticipated burdens.
For many researchers, the end of a post-doctoral fellowship and entry into a junior faculty position can be a time without a map.
Among the biggest obstacles in studying and treating brain tumors are the blood-brain and blood-tumor barriers (BBTB). Generally, just a small amount of drug that is injected into the blood to treat brain tumors is able to penetrate blood vessel walls and accumulate in the brain.
After a 30-year, off-and-on battle with metastatic breast cancer, Australian-born actress and singer Olivia Newton-John died on August 8 at age 73. Best known for her role as Sandy in the 1978 movie musical “Grease,” Newton-John also hit the music charts with singles like “Physical” and “Magic.”
A cancer diagnosis can be difficult to work through in the best of circumstances, but factor in barriers related to language, insurance status, educational achievement, geographic location, income level, and more, and the cancer journey — everything from prevention and screening to diagnosis and treatment — can become nearly impossible to traverse.
When the 21st Century Cures Act went into effect in April 2021, health care organizations began releasing electronic health information (EHI) to patients immediately.
A new study released by the University of Colorado Cancer Center shows that more than 70 percent of breast cancer patients have reported changes that affect their sexual health during and beyond treatment.
For people living with and beyond cancer, one of the most common and limiting side effects is cancer-related fatigue (CRF).
A new study from the University of Colorado Cancer Center explores which lung cancer patients are the best candidates for novel therapies that directly target a gene identified as driving certain cancers.
Some 100 researchers from around the world were in Aurora last week to discuss the latest findings and news around Kaposi sarcoma herpesvirus (KSHV), the virus that causes a type of cancer known as Kaposi sarcoma.
The bad news about endometrial cancer — cancer that begins in the lining of the uterus — is that it is one of the few cancers that is increasing in incidence even as most other cancers are on the decline, thanks to advances in treatment and prevention.
Large B-cell lymphoma (LBCL) is one of the most aggressive lymphomas and accounts for about 30% of all lymphoma diagnoses.
Oncologists have many tools they use to treat cancer, and one of the most commonly used is radiation therapy. In use since the early 1900s, radiation therapy uses high-energy particles or waves — including x-rays, gamma rays, electron beams, and protons — to destroy or damage cancer cells. The machine that delivers radiation therapy has a head that rotates 360 degrees, and patients lie on a special bench that swivels, allowing the radiation to be delivered from any angle.
Ward McNeilly thought he was a goner.
It was summer 2021, and the sarcoma that had started in the Denver resident’s left thigh seemed to be under control, subdued by radiation and chemotherapy following a surgery in 2018 to remove the initial tumor and another surgery in 2019 to remove cancerous tumors in his groin. McNeilly was doing so well, in fact, that his doctors at UCHealth University of Colorado Hospital authorized a “chemo vacation” to give his body a break from some of the side effects of the treatment.
An exciting and innovative area of cancer research is immunoprevention, in which studies focus on preventing cancer before its onset by using vaccines, antibodies, and other immune mechanisms.
Three University of Colorado Cancer Center scientists have received a combined total of almost $2 million in grant funding from the American Cancer Society (ACS) to support research addressing a broad spectrum of cancer prevention, diagnosis, and treatment.
Artificial intelligence and machine learning are among the latest tools being used by cancer researchers to aid in detection and treatment of the disease.
PIK3CA is a gene that makes an enzyme called PI3K, which is involved in many important cell functions. When PIK3CA mutates, however, it can make the PI3K enzyme become overactive and cause cancer cells to grow.
Country music star Toby Keith has been battling stomach cancer, also known as gastric cancer, for the past six months, he announced Sunday on social media.
Jimmy Guerrero’s first diagnosis was a possible stomach ulcer, because it seemed inconceivable that a 26-year-old would have colon cancer.
Richard Duke, PhD, is taking the next step in his long career at the University of Colorado School of Medicine, joining the CU Cancer Center this July as deputy associate director of commercialization. In his new role, Duke will serve as a liaison to center-level oversight, strategic planning, and process improvement for CU Cancer Center commercialization efforts, working closely with CU Innovations and the Colorado AMC SPARK/REACH program.
Researchers have discovered that infiltrating gliomas, a common brain and spinal cord tumor, are shaped by their genetic evolution and microenvironment, a finding that could lead to more targeted treatments.
Bringing with him more than 20 years of experience in gene therapy and personalized medicine, Hatim Sabaawy, MD, PhD, will step into the role of associate director of translational research at the University of Colorado Cancer Center on July 1.
The cancer journey can be a solitary one, whether you’re a patient, a survivor, or a friend or family member of someone who died from the disease.
In recognition of National Cancer Survivors Day on June 5, we wanted to share how far cancer survivorship has come, our efforts at the University of Colorado Cancer Center to further the research that results in survivorship, and some of our survivor stories from the past year.
The median age for receiving a bladder cancer diagnosis is 73, and a significant number of those living with the disease are in their 70s and 80s.
Colorado is known for adventure – from kayaking to skiing, horseback riding to rock climbing, and everything in between. These sports take full advantage of the beauty and challenge of Colorado’s landscape, and often come to define a group of like-minded and spirited individuals who share a passion for adrenaline, community, and focus.
Four research projects conducted by University of Colorado Cancer Center members from the University of Colorado Anschutz Medical Campus and Colorado State University recently each received $50,000 pilot grant funding from the Joint Pilot Program of the CU Cancer Center and CSU Flint Animal Cancer Center.
Molly the golden retriever was a fan of cookies. Whenever there was a plate of them nearby, she kept her eye on it, waiting for her chance to sneak one or five. She was a fan of water, too, even after she had surgery to remove her left front leg following an osteosarcoma, or bone cancer, diagnosis in April 2017.
Among the many lessons collectively learned during the initial months of the worldwide COVID-19 pandemic was this: The experience was uncharted psychological and emotional terrain. It wasn’t uncommon for people across the globe to express uncertainty about how to navigate new stresses and new emotions.
She was recognized by her peers in 2021 for her leadership at the University of Colorado Cancer Center’s Animal Imaging Shared Resource. Now Natalie Serkova, MSc, PhD, is bringing her expertise to a new role: deputy associate director of all shared resources at the CU Cancer Center.
Hormone therapy is often used to treat prostate cancer that has spread to other parts of the body, but many patients develop resistance to hormone therapy, causing their disease to become more aggressive and potentially more deadly.
University of Colorado Cancer Center member Janet Kukreja, MD, assistant professor of urology in the University of Colorado School of Medicine, is taking part in this weekend’s Walk to End Bladder Cancer along with her office staff, fellow physicians, and even some of her patients. For this year’s “virtual” event, hosted by the Bladder Cancer Advocacy Network to kick off Bladder Cancer Awareness Month in May, participants walk in their own cities at their own pace, sharing their progress with others around the country.
Michael Joseph Roark – Mike to his friends – met Mary Jo Dougherty in a ski fitness class taught by Anne Kashiwa at the former International Athletic Club in downtown Denver.
Receiving a cancer diagnosis can feel like crossing the border into a new country, one with its own language, customs, and laws. Following a cancer diagnosis, people may find themselves sprinting to absorb a new vocabulary of often intimidating words.
This year, lung cancer will account for an estimated 130,000 deaths in the United States – approximately 25% of all cancer deaths. Among those deaths, people who are Black will be disproportionately represented.
As a former dancer and dance instructor, CU Cancer Center member Jennifer Raybin, PhD, knows the power the creative arts hold to help people through challenging times. As a nurse practitioner who led the Palliative Care Program at Children’s Hospital Colorado, she knows the creative arts can be especially helpful for children and young adults with cancer. Creative activities help patients deal with symptoms, improve their mood, and even ease disease and treatment symptoms like pain, nausea, and fatigue.
The future of cancer research and care got a little brighter on April 22 as more than 50 biomedical science students from Denver-area high schools came to the University of Colorado Anschutz Medical Campus for Learn About Cancer Day.
The development of the anti-cancer immunotherapy drugs called immune checkpoint inhibitors has improved treatment for many cancer patients, but patients with mucosal melanomas — melanomas that occur not on the skin but in the mucous membranes in the head, neck, eyes, respiratory tract, and genitourinary region — are particularly resistant to immune checkpoint inhibitors for reasons researchers don’t fully understand.
To understand why Beau Gill built a mental cupboard for Jeff and Spike, first you must travel back with him to the small town of Catemaco in Mexico’s state of Veracruz.
At first blush, the numbers aren’t great: Cancer patients who are covered by Medicaid tend to have later-stage disease and higher rates of mortality.
April has been designated National Minority Cancer Awareness Month to bring attention to the health disparities that lead to higher rates of cancer in Black, Hispanic, American Indian/Alaskan Native, and other communities of color.
An enzyme that has been identified as instrumental in the progression of many types of cancer is meeting its match in inhibitors synthesized and evaluated by University of Colorado (CU) Cancer Center researchers.
The National Cancer Institute (NCI) has once again recognized the University of Colorado (CU) Cancer Center as one of the best cancer centers in the country. On March 31, the NCI officially renewed the CU Cancer Center’s “comprehensive” designation with a strong rating, the best ever received at the CU Cancer Center. The award recognizes the center’s strengths in basic, translational, clinical, and population science research, as well as leadership and resources devoted to community outreach and engagement and cancer research, training, and education.
While conducting research for her doctoral dissertation, Channing Tate, PhD, MPH, spoke with 144 older Black adults about hospice care – what they knew about it, whether they’d consider it, what their experiences with hospice had been.
Colorectal cancer, the third most commonly-diagnosed cancer in the United States (excluding skin cancers) and second leading cause of cancer-related mortality, is increasingly affecting people in their 20s and 30s, recently published research shows.
University of Colorado (CU) Cancer Center member Tejas Patil, MD, is one of three researchers to receive a combined $1 million grant from the Hamoui Foundation and LUNGevity Foundation to study RET-positive lung cancer.
A University of Colorado (CU) Cancer Center researcher has found, through extensive data analysis, that the youngest patients with brain tumors – those ages birth to 3 months – have about half the five-year survival rate as children ages 1 to 19.
When Myles Krick started his freshman year of college in fall 2021, he couldn’t help but look back to 15 years ago, when he received the brain cancer diagnosis that made his family worry he might not live long enough to go to college.
Dianne Primavera wouldn’t take no for an answer.
For years, surgery for patients with stage III melanoma — melanoma that has spread to the lymph nodes — involved removing those lymph nodes along with the primary tumor. Known as completion lymph node dissection (CLND), the surgery was meant to ensure that no cancer remained after surgery.
In normal human development, the SIX1 gene is critical for embryonic muscle development. After a person is born and as they mature, SIX1 is downregulated, or becomes less prevalent in cells.
March is Kidney Cancer Awareness Month, and to get the latest information on the disease, we spoke with University of Colorado (CU) Cancer Center member Elaine Lam, MD, FACP, an associate professor of medicine in the Division of Medical Oncology at the University of Colorado School of Medicine.
University of Colorado (CU) Cancer Center researchers have been on the leading edge of developing new therapies for leukemia. One of the most recent breakthrough therapies has been the development of venetoclax, a B-cell lymphoma-2 inhibitor, that that has shown profound results for adults with acute myeloid leukemia (AML) and has become a standard of care for patients with this disease all over the world.
There were a lot of things Jim White thought he’d never do: stay in one place long enough to feel roots grow beneath his feet, meet the love of his life, have a child whose daily joy in discovering the world reignites White’s own joy.
Even as exciting developments are happening in cervical cancer research, an estimated 14,100 new cases of invasive cervical cancer will be diagnosed in the United States this year.
The Tumor-Host Interactions Program (THI) at the University of Colorado Cancer Center has awarded four CU Cancer Center researchers $30,000 each to gain preliminary data using the Multiplex Ion Beam Imager (MIBI) housed in the cancer center’s Human Immune Monitoring Shared Resource (HIMSR) to support a competitive national grant proposal. The selected researchers are expected to submit a national competitive grant proposal within six months of completing their THI-MIBI pilot studies.
Can dietary strategies like intermittent fasting or time-restricted eating help breast cancer survivors prevent their tumors from recurring? It’s a question researchers at the University of Colorado (CU) Cancer Center are looking to answer with a new study funded by a $3 million R01 grant from the National Cancer Institute.
On a mission to increase early detection of esophageal cancer, University of Colorado (CU) Cancer Center member Sachin Wani, MD, is leading a study to see if a novel diagnostic platform can help endoscopists better identify the disease in patients with a condition called Barrett’s esophagus.
On this World Cancer Day, the University of Colorado (CU) Cancer Center looks back to earlier this week when President Biden reignited his Cancer Moonshot initiative, setting ambitious goals to “reduce the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living with and surviving cancer — and by doing this and more, end cancer as we know it today.”
University of Colorado (CU) Cancer Center leader Wells Messersmith, MD, has been named chief medical officer of oncology services at UCHealth. In this new role, Messersmith will oversee cancer care at all UCHealth locations with a focus on expanding advanced treatments and the clinical trials UCHealth offers in partnership with the CU Cancer Center.
Comedian Louie Anderson — known for his stand-up routines, as well as a hosting stint on “Family Feud,” his animated series “Life With Louie,” and a more recent role on the FX comedy series “Baskets” — died January 21of diffuse large B-cell lymphoma. He was 68.
When Colorado Governor Jared Polis declared January National Radon Action Month, he noted that about 50 percent of Colorado homes test at or above the guideline level at which the U.S. Environmental Protection Agency (EPA) recommends remediation.
The American Cancer Society (ACS) released its annual cancer statistics last week, reporting that the risk of dying from cancer in the U.S. has fallen 32% over the past 28 years. Cancer deaths in the U.S. reached their peak in 1991, with 215 out of every 100,000 people dying from cancer, and have been falling ever since, largely due to a decline in the amount of people who smoke.
Carlos J. Castro transferred his care to Elizabeth Kessler, MD, University of Colorado Cancer Center member, after learning about a clinical trial that gave him a new treatment option for his stage 4 prostate cancer.
In the past, molecular and cellular oncology research often began with the idea that cells are cells and proteins are proteins, and it didn’t especially matter who provided the sample.
This was another exciting year for the University of Colorado Cancer Center, and we were able to share more than 80 stories spotlighting our members and their research. We also shared the cancer journeys of some of our patients.
Some battles begin before a shot is even fired, with an army building bridges and grading roads, clearing and smoothing the path to make the invading force stronger and more effective.
Of the 18,000 people diagnosed with large B-cell lymphoma each year, only half will be successfully treated with chemotherapy. The 9,000 remaining patients typically have poor outcomes, with only 25% responding to additional, higher-intensity chemotherapy, followed by a stem cell transplant.
The University of Colorado Cancer Center is pleased to announce several leadership transitions that will support the center in its mission to overcome cancer through innovation, discovery, prevention, early detection, multidisciplinary care, and education.
It’s worth noting, in light of recently published research, that a majority of people won’t be diagnosed with cancer in their lifetimes. According to the National Cancer Institute, about 40% of people will, which means 60% won’t.
Sandra Luna-Fineman, MD, treats children and adolescents with cancer from around the U.S. in her role as a pediatric oncologist at Children’s Hospital Colorado, but she knows that children in low- and middle-income countries around the world need her help the most.
At her lowest point, after hearing there wasn’t much more that medicine or science could do for her, Connie Walters asked her best friend and ex-husband, Abel, to stay with her overnight. She wasn’t sure she would wake up and she didn’t want to die alone.
Looking to improve methods to treat patients with sepsis, Richard Tobin, PhD, an assistant research professor of surgical oncology in the University of Colorado School of Medicine, and Laurel Hind, PhD, an assistant professor in the biomedical engineering program at the University of Colorado Boulder, are teaming up to study the role of myeloid-derived suppressor cells (MDSCs) in sepsis.
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.
Lung cancer screening is recommended only for those who are at high risk for the disease — adults ages 50–80 who smoke at least 20 packs a year — but even among members of that high-risk group, screening rates remain low, ranging from 5% to 20% of those eligible for the screening CT scan.
“When you lose hope, you lose everything,” says Ron Randolph. “It’s like you’re in the bottom of a hole and you see this light at the top of the hole. It’s a very small light, but there’s no way to escape.”
Janice Woodward was already a member of the club nobody wants to join — the cancer club, membership involuntary — when she got an irregular mammogram result in May 2019.
The cancer diagnosis came at a time when it seemed as though everything was happening – he was only 37 and soon to become president of the Denver City Council; his three children were ages 4, 6, and 9; he had just run the BOLDERBoulder 10K.
There are two things most people believe about lung cancer, says Jamie Studts, PhD, co-leader of the Cancer Prevention & Control Program at the CU Cancer Center: Those who suffer from it most likely caused it by using tobacco, and the prognosis for surviving the disease is poor.
When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she’ll receive, where it will happen.
Three researchers from the University of Colorado Cancer Center have received grants from the V Foundation, a cancer research nonprofit founded in 1993 by college basketball coach Jimmy Valvano, who died of cancer.
In a grim reminder of the toll COVID-19 can take even among those who are vaccinated against it, former Secretary of State Colin Powell died Monday of complications from the virus. His family said Powell, who was 84, was fully vaccinated against the disease.
The first time Caley Kurchinski had to think about a double mastectomy, she was only 16. Her mother had died at age 36 from breast cancer, when Caley was 6. When she became a teenager, Caley’s family physician began telling her she needed to get genetic testing.
Erica Ramsthaler was only given three years to live when she was first diagnosed with colorectal cancer, but after transferring her care to the University of Colorado Cancer Center, she is thriving more than four years later.
Kirsten Stewart was just putting on lotion, like she does every morning after her shower. That particular morning, though, she noticed something different: a lump that hadn’t been there before and that definitely wasn’t normal. She was only 30 years old.
During a roundtable event, Peter Forsberg, MD, discussed data from several trials of selinexor in patients with relapsed/refractory multiple myeloma.
November is Pancreatic Cancer Awareness Month. Laura Foote shares her story to bring hope and express gratitude.
Men are three to four times more likely than women to develop bladder cancer, but the disease tends to be deadlier in females. Why?
New therapeutic addresses need in patients suffering with cold and refractory tumors.